Latest Insider Transactions at Universal Biosensors Inc (UBI)
This section provides a real-time view of insider transactions for Universal Biosensors Inc (UBI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of UNIVERSAL BIOSENSORS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of UNIVERSAL BIOSENSORS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 27
2024
|
Graham A Mc Lean Director |
BUY
Grant, award, or other acquisition
|
Indirect |
275,000
+20.29%
|
$0
$0.11 P/Share
|
|
May 27
2024
|
John Stewart Sharman Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
275,000
+14.98%
|
$0
$0.11 P/Share
|
|
May 27
2024
|
Craig E. Coleman Director |
BUY
Open market or private purchase
|
Indirect |
1,421,293
+1.6%
|
$0
$0.11 P/Share
|
|
May 01
2024
|
Craig E. Coleman Director |
BUY
Open market or private purchase
|
Indirect |
29,506,606
+21.83%
|
$0
$0.15 P/Share
|
|
May 01
2024
|
Graham A Mc Lean Director |
BUY
Grant, award, or other acquisition
|
Indirect |
180,116
+18.28%
|
$0
$0.15 P/Share
|
|
May 01
2024
|
Judith Ann Smith Director |
BUY
Grant, award, or other acquisition
|
Indirect |
99,077
+18.28%
|
$0
$0.15 P/Share
|
|
May 01
2024
|
John Stewart Sharman Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
40,000
+3.92%
|
$0
$0.15 P/Share
|
|
May 01
2024
|
John Stewart Sharman Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,055
+18.28%
|
$0
$0.15 P/Share
|
|
Mar 25
2024
|
John Stewart Sharman Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000,000
-92.59%
|
-
|
|
Mar 25
2024
|
John Stewart Sharman Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
1,000,000
+43.93%
|
-
|
|
Mar 25
2024
|
Craig E. Coleman Director |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+1.73%
|
$0
$0.2 P/Share
|
|
Mar 25
2024
|
John Stewart Sharman Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,364,666
+48.58%
|
$0
$0.2 P/Share
|
|
Dec 11
2023
|
Graham A Mc Lean Director |
BUY
Grant, award, or other acquisition
|
Indirect |
75,000
+10.71%
|
$0
$0.2 P/Share
|
|
Sep 11
2023
|
Craig E. Coleman Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+11.71%
|
$0
$0.22 P/Share
|
|
Jun 30
2023
|
David L Hoey Director |
BUY
Open market or private purchase
|
Direct |
95,983
+12.66%
|
$0
$0.17 P/Share
|
|
Mar 14
2023
|
Graham A Mc Lean Director |
BUY
Grant, award, or other acquisition
|
Indirect |
150,000
+21.43%
|
$0
$0.25 P/Share
|
|
Jan 01
2023
|
Salesh Balak Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+11.4%
|
-
|
|
Jan 01
2023
|
John Stewart Sharman Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+38.46%
|
-
|
|
Dec 12
2022
|
Graham A Mc Lean Director |
BUY
Grant, award, or other acquisition
|
Indirect |
200,000
+33.33%
|
$0
$0.23 P/Share
|
|
Nov 16
2022
|
Craig E. Coleman Director |
BUY
Open market or private purchase
|
Indirect |
17,848
+2.66%
|
$0
$0.24 P/Share
|
|
Nov 15
2022
|
Craig E. Coleman Director |
BUY
Open market or private purchase
|
Indirect |
82,152
+11.44%
|
$0
$0.24 P/Share
|
|
Nov 11
2022
|
Craig E. Coleman Director |
BUY
Open market or private purchase
|
Indirect |
50,000
+8.28%
|
$0
$0.25 P/Share
|
|
Aug 17
2022
|
Craig E. Coleman Director |
BUY
Open market or private purchase
|
Indirect |
200,000
+28.42%
|
$0
$0.28 P/Share
|
|
Jun 09
2022
|
Craig E. Coleman Director |
BUY
Open market or private purchase
|
Indirect |
25,000
+7.61%
|
$0
$0.38 P/Share
|
|
Jun 01
2022
|
Graham A Mc Lean Director |
BUY
Grant, award, or other acquisition
|
Indirect |
96,613
+32.57%
|
$0
$0.46 P/Share
|
|
May 31
2022
|
Graham A Mc Lean Director |
BUY
Grant, award, or other acquisition
|
Indirect |
3,387
+3.17%
|
$0
$0.46 P/Share
|
|
May 27
2022
|
Judith Ann Smith Director |
BUY
Grant, award, or other acquisition
|
Indirect |
43,796
+11.3%
|
$0
$0.77 P/Share
|
|
May 27
2022
|
Craig E. Coleman Director |
BUY
Open market or private purchase
|
Indirect |
1,920,000
+50.0%
|
-
|
|
May 27
2022
|
Craig E. Coleman Director |
BUY
Open market or private purchase
|
Indirect |
1,920,000
+50.0%
|
-
|
|
May 27
2022
|
Craig E. Coleman Director |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+50.0%
|
$0
$0.57 P/Share
|
|
May 27
2022
|
Craig E. Coleman Director |
BUY
Open market or private purchase
|
Indirect |
27,183,617
+12.64%
|
$0
$0.66 P/Share
|
|
May 27
2022
|
Salesh Balak Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+0.59%
|
$0
$0.77 P/Share
|
|
May 24
2022
|
Craig E. Coleman Director |
BUY
Open market or private purchase
|
Indirect |
48,620
+15.33%
|
$0
$0.48 P/Share
|
|
May 12
2022
|
Graham A Mc Lean Director |
BUY
Grant, award, or other acquisition
|
Indirect |
64,962
+39.38%
|
$0
$0.5 P/Share
|
|
May 11
2022
|
Graham A Mc Lean Director |
BUY
Grant, award, or other acquisition
|
Indirect |
35,038
+50.0%
|
$0
$0.5 P/Share
|
|
Feb 24
2022
|
John Stewart Sharman Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+50.0%
|
-
|
|
Feb 24
2022
|
Salesh Balak Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+8.18%
|
-
|
|
Nov 05
2021
|
Craig E. Coleman Director |
BUY
Open market or private purchase
|
Indirect |
329,613
+1.14%
|
$0
$0.75 P/Share
|
|
Nov 03
2021
|
Craig E. Coleman Director |
BUY
Open market or private purchase
|
Indirect |
152,638
+0.54%
|
$0
$0.75 P/Share
|
|
Nov 01
2021
|
Craig E. Coleman Director |
BUY
Open market or private purchase
|
Indirect |
896,506
+3.09%
|
$0
$0.73 P/Share
|
|
Aug 19
2021
|
Salesh Balak Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+11.54%
|
-
|
|
Jan 07
2021
|
Craig E. Coleman Director |
SELL
Open market or private sale
|
Indirect |
12,559,109
-31.55%
|
-
|
|
Dec 11
2020
|
Salesh Balak Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+13.05%
|
-
|
|
Nov 02
2020
|
Judith Ann Smith Director |
BUY
Grant, award, or other acquisition
|
Indirect |
200,000
+40.0%
|
$0
$0.31 P/Share
|